Chione Ltd has sold stock and made no open-market buys since May 2016

10% owner at Acrivon Therapeutics, Inc., and 1 other company

SEC CIK 0001590232 · Filings on SEC.gov ↗

$0Bought

$30.1MSold

NoneLast buy

Companies

Every filing

21 filings since May 2016, newest first

ACRVSell

Acrivon Therapeutics, Inc.

10% owner

$72KJun 14

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$619K−2.0%Mar 4

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$7.1M−19.0%Feb 27

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$3.5M−2.0%Sep 7

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$5.3M−3.0%Sep 4

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$4.2M−3.0%Aug 29

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$1.5M−1.0%Aug 9

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$560KJul 25

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$2.4M−1.0%Jul 23

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$926K−1.0%Jul 18

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$151KJun 27

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$60KJun 15

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$419K−1.0%Jun 10

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$370KJun 8

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$172KJun 6

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$718K−1.0%Jun 1

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$449K−1.0%May 27

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$802K−1.0%May 23

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$520K−1.0%May 19

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$83KMay 17

KPTISell

Karyopharm Therapeutics Inc.

10% owner

$263KMay 12

Filings come from SEC EDGAR. Not investment advice.